Improvement of Total Knee Arthroplasty Effectiveness Using Preoperative Prehabilitation
TKA-PREHAB
1 other identifier
interventional
64
1 country
1
Brief Summary
Total knee arthroplasty (TKA) is the most effective treatment for stage III-IV knee osteoarthritis (OA). However, up to 30% of patients remain dissatisfied due to periarticular functional insufficiency, pain, and movement limitations. This study aims to improve TKA outcomes by developing and implementing a multimodal prehabilitation approach based on OA phenotypes (chronic pain, inflammatory, biomechanical) to correct clinical and functional disorders preoperatively, thereby enhancing postoperative recovery and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Jan 2023
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
January 1, 2026
3 years
August 24, 2026
August 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
WOMAC score change
Assessment of osteoarthritis severity and functional status using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Lower scores indicate better outcomes.
Baseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-op
VAS pain score change
Assessment of pain intensity using the Visual Analogue Scale (VAS), score 0-10. Lower scores indicate less pain.
Baseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-op
m. rectus femoris action potential amplitude
Assessment of neuromuscular control and muscle activity using surface electromyography (EMG), measured in mkV.
Baseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-op
Two Minute Walking Test (2MWT) distance
Assessment of functional mobility and endurance, measured in meters covered in 2 minutes.
Baseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-op
Secondary Outcomes (2)
KOOS score change
Baseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-op
Timed Up and Go (TUG) test time
Baseline, 72 hours post-op, 4 weeks post-op, 12 weeks post-op
Study Arms (2)
Main group (prehabilitation)
EXPERIMENTALPatients (n=31) receiving a 4-week multimodal prehabilitation complex prior to TKA, tailored to their specific OA phenotype (chronic pain, inflammatory, or biomechanical). The complex includes mechanotherapy, breathing exercises, psychological support, kinesiotaping, and phenotype-specific physiotherapy (SMT, magnetotherapy, or robotic mechanotherapy).
Control group (standard care)
NO INTERVENTIONPatients (n=33) receiving standard preoperative examination and routine care without a structured, phenotype-based prehabilitation complex prior to TKA.
Interventions
A 4-week preoperative program including active/passive mechanotherapy, breathing exercises, psychological support, and phenotype-specific interventions (SMT for chronic pain, magnetotherapy for inflammation, robotic mechanotherapy for biomechanical restrictions) combined with kinesiotaping, aimed at correcting clinical and functional disorders before TKA.
Eligibility Criteria
You may qualify if:
- Age 18 to 70 years
- Verified knee OA stage III-IV (Kellgren-Lawrence)
- Intermalleolar distance ≤ 8 cm (valgus) or intercondylar distance ≤ 8 cm (varus)
- Limb shortening ≤ 2 cm
- BMI \< 35 kg/m²
- Barthel Index \> 65 points
- No decompensation of concomitant chronic diseases
- No recent physiotherapy or intra-articular injections (within 1-3 months)
- Signed informed consent
You may not qualify if:
- Age \< 18 or \> 70 years
- Limb shortening \> 2 cm
- Previous knee surgery or trauma indicating secondary OA
- BMI ≥ 35 kg/m²
- Decompensated chronic infectious or non-infectious diseases
- Inability to comply with the follow-up schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinics of Samara State Medical University, Department of Traumatology and Orthopedics
Samara, Samara Oblast, 443099, Russia
Related Links
- Kotelnikov GP, Kolsanov AV, Moseev OI, et al. Variability of preoperative rehabilitation in preparation for primary arthroplasty in patients with knee osteoarthritis. Vestnik meditsinskogo instituta "REAVIZ". 2024;14(4):29-38.
- Kotelnikov GP, Kolsanov AV, Moseev OI, et al. Application of the developed prehabilitation complex in total knee arthroplasty. Physical and Rehabilitation Medicine. 2025;7(2):50-62.
- Moseev OI, Kotelnikov GP, Kudashhev DS, et al. Prehabilitation of patients in total knee arthroplasty. XII All-Russian Priorov Forum. Moscow, 2025:167-168.
- Moseev OI, Kotelnikov GP, Kudashhev DS. Expectations, satisfaction and quality of life of patients before and after primary total knee arthroplasty. Postgraduate Readings 2025. Samara, 2025:78-80.
- Kotelnikov GP, Kolsanov AV, Kudashhev DS, Moseev OI. Analysis of the results of applying a new approach to prehabilitation of patients in total knee arthroplasty. Science and Innovations in Medicine. 2026;11(2):144-150.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dmitry Sergeevich Kudashhev, MD, PhD, Associate Professor
Samara State Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Masking is not possible due to the nature of the prehabilitation and surgical procedures; both the operator and the patient are aware of the group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2026
First Posted
August 27, 2026
Study Start
January 1, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
August 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share